FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-18.Following & alerts
- Reported transaction lines
- 1
- Buy lines
- 0
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-111
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Trimarchi Thomas President and CFO · BridgeBio Pharma, Inc. | BBIO BridgeBio Pharma, Inc. | Other transactionFiling detailsSEC transaction code F Common Stock · Direct ownership · Reported balance after transaction: 313748 · Securities delivered or withheld for tax or exercise payment · Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 41,193 shares of Common Stock underlying the Reporting Person's RSUs. | 2026-11-16 | 2026-11-18 | 22,781 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.
Advertisement